Don’t Ignore a Weaker Handshake: 1 in 4 Adults Over 80 Has Sarcopenia
When holding your parents' hands, a noticeably weaker grip should not be brushed off as a harmless part of aging.
Search results for "clinical trials"
Samsung Bioepis Seeks South Korean Approval for Keytruda Biosimilar SB27
Samsung Bioepis announced on Aug. 10 that it has submitted a marketing authorization application to South Korea's Ministry of Food and Drug Safety...
AI Tracks Lung Scarring: 4-Percentage-Point Rise in One Year Signals Danger
Researchers have established an artificial intelligence benchmark to quantify the progression of idiopathic pulmonary...
Scalp-Injected RNA Hair Loss Drug Completes Phase 1b Dosing in Australia
OliX announced on August 4 that it has completed patient dosing in the Australian Phase 1b clinical trial for OLX104C...
Antihistamines Provide Minimal Relief for Atopic Dermatitis Itch, Study Finds
Antihistamines commonly used to ease itching from atopic dermatitis do not deliver a large enough benefit for patients...
Timing of Immune Cell Entry Dictates Anti-Cancer Defense in Hard-to-Treat Brain Tumors
Some immune cells surrounding a tumor actively attack it, while others create conditions that help it survive.
AI Platform Replaces Animal Models to Accelerate Parkinson’s Cell Therapy
Researchers are launching an international joint study that leverages artificial intelligence to evaluate whether...
Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short
Novartis has discontinued the development of Lu-NeoB, an experimental cancer therapy designed to seek out tumor cells...
Placebo Outperforms TG-C: Data Errors and Stock Volatility Cloud Kolon TissueGene’s Phase 3 Trial
Kolon TissueGene’s knee osteoarthritis cell and gene therapy, TG-C, has failed to achieve statistical significance on...
Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven
Eli Lilly and Company’s next-generation obesity treatment, retatrutide, reduced body weight by up to 22.